Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.535 USD | +0.56% | -1.13% | +92.67% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+92.67% | 36.36M | |
+1.91% | 42.59B | |
+8.52% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+9.12% | 24.81B | |
-24.35% | 18.17B | |
+28.84% | 12.05B | |
-2.77% | 11.7B | |
+6.74% | 11.1B |
- Stock Market
- Equities
- BCLI Stock
- News Brainstorm Cell Therapeutics Inc.
- Brainstorm Cell Therapeutics : Completes Dosing in Phase 2 Trial of NurOwn to Treat MS; Shares Rise Pre-Bell